Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Bisoprolol Mylan
Bisoprolol fumarate 1.25mg
Film coated tablet
Mylan New Zealand Limited
Mylan Laboratories Limited, Sinnar, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Bisoprolol Mylan
Bisoprolol fumarate 2.5mg
Film coated tablet
Mylan New Zealand Limited
Mylan Laboratories Limited, Sinnar, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Bisoprolol Mylan
Bisoprolol fumarate 3.75mg
Film coated tablet
Mylan New Zealand Limited
Mylan Laboratories Limited, Sinnar, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Bisoprolol Mylan
Bisoprolol fumarate 5mg
Film coated tablet
Mylan New Zealand Limited
Mylan Laboratories Limited, Sinnar, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Bisoprolol Mylan
Bisoprolol fumarate 7.5mg
Film coated tablet
Mylan New Zealand Limited
Mylan Laboratories Limited, Sinnar, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Bisoprolol Mylan
Bisoprolol fumarate 10mg
Film coated tablet
Mylan New Zealand Limited
Mylan Laboratories Limited, Sinnar, India
|
Dated this 13th day of November 2017.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz